Best Supplements for Reduced Hospitalization Duration
Ranked by research evidence. Compare 9 supplements across 13 papers from the biomedical literature, with effect direction, evidence strength, and dose range for each.
Top picks by evidence
- Moderate evidence3 studies
Across 3 studies, all 3 reported beneficial effects on reducing hospitalization duration, with mixed effect sizes (small to large). The most-studied population was children with acute gastroenteritis (2 studies), with one study in preterm neonates. No consistent dose range was reported.
- Low evidence3 studies
Across 3 studies, 3 reported beneficial effects of Lactobacillus reuteri UALre-16 on reducing hospitalization duration, with effect sizes ranging from small to large. The evidence is strongest in clinical populations of children with acute gastroenteritis and preterm neonates, though the small sample sizes and conflicting effect magnitudes limit certainty. The predominant effect size is mixed, as two studies show small effects and one shows a large effect.
Top combinations for Reduced Hospitalization Duration
most supplement research is combination research- Low evidence
All 3 studies report a beneficial effect of the combination of Lactobacillus reuteri MAK02L14R and Lactobacillus reuteri UALre-16 on reduced hospitalization duration, with effect sizes ranging from small to large. Two of the 3 studies reached statistical significance. Compared to the solo syntheses, the combination evidence does not show stronger or weaker effects—outcomes are similar, likely because both solo and combination studies tested the same underlying strains (DSM 17938) due to naming inconsistencies.
- ModerateLactobacillus reuteri MAK02L14RAcross 3 studies, all 3 reported beneficial effects on reducing hospitalization duration, with mixed effect sizes (small to large). The most-studied population was children with acute gastroenteritis (2 studies), with one study in preterm neonates. No consistent dose range was reported.3 beneficial3 studies
- LowLactobacillus reuteri UALre-16Across 3 studies, 3 reported beneficial effects of Lactobacillus reuteri UALre-16 on reducing hospitalization duration, with effect sizes ranging from small to large. The evidence is strongest in clinical populations of children with acute gastroenteritis and preterm neonates, though the small sample sizes and conflicting effect magnitudes limit certainty. The predominant effect size is mixed, as two studies show small effects and one shows a large effect.3 beneficial3 studies